These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4139412)

  • 1. Editorial: Treatment of malignant melanoma.
    Lancet; 1974 Nov; 2(7889):1119-20. PubMed ID: 4139412
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemoimmunotherapy of disseminated malignant melanoma with dimethyl triazeno imidazole carboxamide and bacillus calmette--guérin.
    Gutterman JU; Mavligit G; Gottlieb JA; Burgess MA; McBride CE; Einhorn L; Freireich EJ; Hersh EM
    N Engl J Med; 1974 Sep; 291(12):592-7. PubMed ID: 4851001
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter: Treatment of malignant melanoma.
    Gutterman JU; Mavligit GM; Reed RC; Hersh EM
    Lancet; 1974 Dec; 2(7894):1460. PubMed ID: 4140384
    [No Abstract]   [Full Text] [Related]  

  • 4. Letter: Treatment of malignant melanoma.
    Constanza ME; Nathanson L
    Lancet; 1974 Dec; 2(7896):1565. PubMed ID: 4140995
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemotherapy of malignant melanoma.
    Luce JK
    Cancer; 1972 Dec; 30(6):1604-15. PubMed ID: 4565819
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical experience with 5-(3,3-bis(2-chloroethyl)-1-triazeno)imidazole-4-carboxamide (NSC-82196) in the treatment of metastatic malignant melanoma.
    Falkson G; Van der Merwe AM; Falkson HC
    Cancer Chemother Rep; 1972 Oct; 56(5):671-7. PubMed ID: 4569061
    [No Abstract]   [Full Text] [Related]  

  • 7. Mumps virus and BCG vaccine in metastatic melanoma.
    Minton JP
    Arch Surg; 1973 Apr; 106(4):503-6. PubMed ID: 4572347
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapy of malignant melanoma with an imidazole carboxamide and bis-chloroethyl nitrosourea.
    Costanza ME; Nathanson L; Lenhard R; Wolter J; Colsky J; Oberfield RA; Schilling A
    Cancer; 1972 Dec; 30(6):1457-61. PubMed ID: 4641757
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chemotherapy of malignant melanoma].
    Wagenknecht L
    Schweiz Med Wochenschr; 1973 Oct; 103(41):1426-8. PubMed ID: 4127413
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of imidazole-4-carboxamide, 5-(3,3-dimethyl-1-triazeno) on immunity in patients with malignant melanoma.
    Bruckner HW; Mokyr MB; Mitchell MS
    Cancer Res; 1974 Jan; 34(1):181-3. PubMed ID: 4588545
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunotherapy of cancer].
    Mäkelä O; Kaartinen M
    Duodecim; 1973; 89(18):1257-62. PubMed ID: 4771796
    [No Abstract]   [Full Text] [Related]  

  • 12. Progress of immunotherapy in the treatment of malignant melanoma.
    Ariyan S
    Yale J Biol Med; 1975 Nov; 48(5):423-9. PubMed ID: 1108459
    [No Abstract]   [Full Text] [Related]  

  • 13. Dacarbazine for malignant melanoma.
    Med Lett Drugs Ther; 1974 Mar; 16(6):27-8. PubMed ID: 4817357
    [No Abstract]   [Full Text] [Related]  

  • 14. Letter: Chemoimmunotherapy of malignant melanoma.
    N Engl J Med; 1975 Jan; 292(3):159-60. PubMed ID: 1196343
    [No Abstract]   [Full Text] [Related]  

  • 15. Adjuvant therapy in malignant melanoma: a trial of immunotherapy. chemotherapy, and combined treatment.
    Kaufman SD; Cosimi AB; Wood WC; Carey RW
    Recent Results Cancer Res; 1978; 68():380-6. PubMed ID: 752874
    [No Abstract]   [Full Text] [Related]  

  • 16. Controlled study for prolonged chemotherapy, immunotherapy, and chemotherapy plus immunotherapy as an adjuvant to surgery in malignant melanoma (Trial 6): preliminary report.
    Veronesi U; Beretta G
    Recent Results Cancer Res; 1978; 68():375-9. PubMed ID: 752873
    [No Abstract]   [Full Text] [Related]  

  • 17. [Polychemotherapy with 5-(3,3 dimethyl-1-triazeno)imidazole-4-carboxamide (DTIC; NSC-45388), 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU, NSC-409962) and vincristine (NSC-67574) in the metastatic phase of melanoma].
    Beretta G; Bajetta E; Bonadonna G; Tancini G; Orefice S; Veronesi U
    Tumori; 1973; 59(3):239-48. PubMed ID: 4729646
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunotherapy for recurrent malignant melanoma: efficacy of BCG in prolonging the postoperative disease-free interval and survival.
    Gutterman JU; Richman SP; McBride CM; Burgess MA; Bartold SL; Kennedy A; Gehan EA; Mavligit G; Hersh EM
    Recent Results Cancer Res; 1978; 68():359-62. PubMed ID: 752870
    [No Abstract]   [Full Text] [Related]  

  • 19. Bacillus Calmette-Guérin immunotherapy in combination with DTIC (NSC-45388) for the treatment of malignant melanoma.
    Gutterman JU; Mavligit GM; Reed R; Burgess MA; Gottlieb J; Hersh EM
    Cancer Treat Rep; 1976 Feb; 60(2):177-82. PubMed ID: 769970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The chemotherapy of malignant melanoma in Nebraska.
    Foley JF; Lemon HM; Kessinger A
    Nebr Med J; 1973 Jun; 58(6):188-96. PubMed ID: 4708217
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.